THE LONG-TERM SAFETY AND EFFICACY OF TADALAFIL 5MG ONCE-DAILY IN MEN WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS)

被引：0
|
作者：
Donatucci, C. [1 ]
Brock, G. [2 ]
Goldfischer, E. [3 ]
Pommerville, P. [4 ]
Elion-Mboussa, A. [5 ]
Kissel, J. [5 ]
Viktrup, L. [5 ]
机构：
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
[2] Univ Western Ontario, Dept Surg, St Josephs Hlth Care London, London, ON N6A 3K7, Canada
[3] Hudson Valley Urol, Ctr Poughkeepsie, Poughkeepsie, NY USA
[4] Can Med Clin Res Inc, Victoria, BC, Canada
[5] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60973-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [41] Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
    Zhong-Wei Xu
    Chun-Gao Zhou
    Wei Tian
    Hai-Bin Shi
    Sheng Liu
    CardioVascular and Interventional Radiology, 2022, 45 : 1801 - 1809
  • [42] Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?
    Speakman, Mark J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (11) : 680 - 689
  • [43] Tadalafil 5mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies
    Nishizawa, Osamu
    Yoshida, Masaki
    Takeda, Masayuki
    Yokoyama, Osamu
    Morisaki, Yoji
    Murakami, Masahiro
    Viktrup, Lars
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 378 - 384
  • [44] Achieving the total approach in lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management
    O'Leary, M
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 25 - 33
  • [45] The impact of treatment on lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) progression
    Berges, R
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 12 - 17
  • [46] Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Daisuke Gotoh
    Kazumasa Torimoto
    Yosuke Morizawa
    Shunta Hori
    Yasushi Nakai
    Makito Miyake
    Kiyohide Fujimoto
    BMC Research Notes, 15
  • [47] Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
    Cavanaugh, Dana
    Urbanucci, Alfonso
    Mohamed, Nihal E.
    Tewari, Ashutosh K.
    Figueiro, Mariana
    Kyprianou, Natasha
    PROSTATE, 2024, 84 (05): : 417 - 425
  • [48] Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Gotoh, Daisuke
    Torimoto, Kazumasa
    Morizawa, Yosuke
    Hori, Shunta
    Nakai, Yasushi
    Miyake, Makito
    Fujimoto, Kiyohide
    BMC RESEARCH NOTES, 2022, 15 (01)
  • [49] Identifying patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) at risk for progression
    Jiménez-Cruz, F
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 6 - 12
  • [50] Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Hernandez, Carlos
    Estivill, Eduard
    Prieto, Marta
    Badia, Xavier
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (04) : 1033 - 1038
12345